Objective-Reactive oxygen species-generating nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase proteins (Noxs) are involved in cell differentiation, migration, and apoptosis. Nox4 is unique among Noxs in being constitutively active, and its subcellular localization may therefore be particularly important. In this study, we identified and characterized a novel nuclear-localized 28-kDa splice variant of Nox4 in vascular cells. Approach and Results-Nox4 immunoreactivity was noted in the nucleus and nucleolus of vascular smooth muscle cells and multiple other cell types by confocal microscopy. Cell fractionation, sequence analyses, and siRNA studies indicated that the nuclear-localized Nox4 is a 28-kDa splice variant, Nox4D, which lacks putative transmembrane domains. Nox4D overexpression resulted in significant NADPH-dependent reactive oxygen species production as detected by several different methods and caused increased phosphorylation of extracellular-signal-regulated kinase1/2 and the nuclear transcription factor Elk-1. Overexpression of Nox4D could also induce DNA damage as assessed by γ-H2AX phosphorylation. These effects were inhibited by a single amino acid substitution in the Nox4D NADPH-binding region. Conclusions-Nox4D is a nuclear-localized and functionally active splice variant of Nox4 that may have important pathophysiologic effects through modulation of nuclear signaling and DNA damage. (Arterioscler Thromb Vasc Biol. 2013;33:e104-e112.)
N icotinamide adenine dinucleotide phosphate (NADPH)-oxidase family proteins (Noxs) are reactive oxygen species (ROS)-generating enzymes that are involved in diverse physiological and pathophysiological processes. [1] [2] [3] Seven family members have been identified that are each based on a distinct catalytic subunit, namely Noxs1-5 and Duox1-2. Nox1, Nox2, Nox4, and Nox5 may be expressed in cardiovascular cells and have differing requirements for additional proteins subunits that associate with the catalytic core to form the active enzyme complex. Nox enzymes have been found to be involved in processes, such as vascular smooth muscle cell (VSMC) and endothelial cell migration, proliferation, angiogenesis, and vascular and cardiac hypertrophy, through the modulation of redox-sensitive signaling cascades. [1] [2] [3] However, the specific roles of individual Noxs remain to be fully clarified. Recent studies have reported distinct functions for different Nox isoforms that are coexpressed in the same cell type. For example, Nox1, but not Nox4, mediates angiotensin II-induced VSMC hypertrophy. 4, 5 Endothelial cell Nox4 was found to have vasodilator effects in contrast to Nox2 expressed in the same cell type. 6 In the heart, cardiomyocyte Nox4 mediated protective signaling in response to pressure overload, whereas Nox2 mediated detrimental signaling. 7 Possible reasons for these differences include distinct subcellular localization and coupling to distinct signal transduction cascades for different Noxs.
Among the Nox proteins, Nox4 is unique in that it constitutively generates ROS. [8] [9] [10] [11] The targets of ROS generated by Nox4 and other Noxs include protein kinases and protein phosphatases that counteract the activation of kinase signaling cascades. The ROS-dependent modulation of function of kinases, phosphatases, and other proteins generally involves specific oxidative modification of amino acid residues; for example, reactive cysteines. Such signaling modifications are believed to require the spatially localized production of ROS in specific subcellular compartments. For example, Nox1-or Nox2-mediated ROS production in endosomes is involved in interleukin 1-dependent activation of nuclear factor-κB. 12, 13 In cardiomyocytes, Nox2-dependent ROS production at the sarcolemma was recently implicated in the regulation of calcium release from ryanodine receptors.
14 Nox4-generated ROS were demonstrated to oxidize and inactivate the phosphotyrosine phosphatase, PTP1B, in the endoplasmic reticulum (ER) of endothelial cells, which served as a regulatory switch for epidermal growth factor receptor trafficking and signaling. 15 The subcellular localization of Nox4 is likely to be especially important, given its constitutive activity, unlike isoforms, such as Nox1 or Nox2, that require agonist activation. However, its subcellular distribution remains controversial, at least in part attributable to the lack of sufficiently specific or characterized antibodies. Nox4 has been reported to be variably present in the ER, 15, 16 mitochondria, 17 cytoskeleton, 4 plasma membrane, 18 and nucleus 19 in different cell types. Here, we report that a 28-kDa splice variant of Nox4 that lacks transmembrane domains (Nox4D) is localized to the nucleus and nucleolus in VSMC and other cell types. Furthermore, this isoform is functionally active and can modulate nuclear signal transduction.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Nuclear-Localized Nox4 Immunoreactivity
We used a well-validated polyclonal antibody directed against the C-terminal region of Nox4 11, 20, 21 to investigate the localization of endogenous Nox4 by immunofluorescence in several cell types, including VSMC, endothelial cells, fibroblasts, and cardiomyocytes. A diffuse reticular staining pattern through the cell that colocalized with an ER marker, protein disulfide isomerase, was evident in most cell types ( Figures 1A and 2 ) as reported previously. 15, 16 In addition, however, there was strong focal and granular Nox4 immunostaining within the nucleus in all cell types. Electron microscopy indicated that the focal Nox4 staining was in the nucleolus ( Figure 1C ). We confirmed that the focal intranuclear staining was nucleolar by costaining with 2 different nucleolar markers, nucleophosmin and fibrillarin ( Figure 1B) . Preincubation of the Nox4 antibody with the antigenic peptide against which it was raised completely abolished both the perinuclear and nucleolar staining, verifying the specificity of antigen-antibody interaction ( Figure 1D ). Furthermore, treatment with a prevalidated Nox4 siRNA to knock down Nox4 protein expression also abolished staining as compared with a scrambled siRNA ( Figure 3A ).
Nuclear-Localized Nox4 Is a 28-kDa Nox4 Splice Variant
To confirm nuclear and nucleolar localization, VSMCs were fractionated into membrane and nuclear fractions. Immunoblotting for Nox4 demonstrated an ≈65-kDa band corresponding to the expected molecular size of Nox4 but also a more prominent ≈28-kDa band ( Figure 4A ). Both bands were depleted after treating with the Nox4 siRNA ( Figure 3B ). The ≈28-kDa band was the dominant band in the nuclear fraction and hardly detectable in the membrane fraction ( Figure 4B ). The specificity of the band was confirmed using antigenic peptide for competitive inhibition during primary antibody incubation (data not shown). We confirmed a 28-kDa Nox4 immunoreactive band in human embryonic kidney (HEK293) cells, and in these cells could also purify the nucleolar fraction, which contained the same band ( Figure 4C ). The purity of cell fractions was confirmed using fraction-specific antigens ( Figure 4C) .
A previous study reported the presence of 4 Nox4 splice variants, namely Nox4B, C, D, and E, in lung tissue. 22 Among these, Nox4D has a molecular size of 28 kDa. Real-time polymerase chain reaction of VSMC using primers corresponding to the 3′ and 5′ ends of full-length Nox4, followed by nucleotide sequencing of bands, revealed the presence of mRNAs corresponding to full-length Nox4 and Nox4D ( Figure 4D ). This suggested that the 28-kDa band in nuclear lysates was Nox4D. To distinguish between Nox4D or a cleavage product of Nox4, we used siRNAs against Nox4 exon 14 (which is expressed in Nox4D) and Nox4 Exon 3 (which is not expressed in Nox4D). The siRNA targeted against exon 14 significantly depleted the 28-kDa band and nuclear immunoreactivity as compared with the siRNA against exon 3 ( Figure  4E and 5A). We next overexpressed Nox4 and Nox4D in VSMC using adenoviral vectors, confirming protein expression by immunoblotting ( Figure 4F ). Immunofluorescence studies revealed that overexpressed Nox4 localized to the perinuclear region as described previously 15, 16 ( Figure 5B, top). However, overexpressed Nox4D localized mainly to the nucleus and nucleolus, although some perinuclear staining was also evident ( Figure  5B , bottom).
Nox4D Generates ROS
Although Nox4D is a truncated form of full-length Nox4, it retains NADPH-and FAD-binding domains required for electron transfer activity. 23 VSMC overexpressing Nox4D showed a >2-fold increase in catalase-inhibitable H 2 O 2 production compared with β-galactosidase (βGal)-overexpressing cells and produced comparable ROS levels with Nox4-overexpressing cells ( Figure 6A ). The capacity for electron transfer was further assessed by an nitroblue tetrazolium assay.
24 Nox4D-overexpressing VSMC had an ≈3-fold increase in activity compared with βGal-overexpressing control cells, which was inhibited by the flavoprotein inhibitor diphenyleneiodonium (DPI, 10 μmol/L; Figure 6B ). We analyzed NADPH-dependent O 2 − generation in whole-cell and nuclear lysates of Nox4D-overexpressing cells, using lucigenin-enhanced chemiluminescence. Both whole-cell and nuclear NADPHdependent ROS generation was significantly higher in Nox4D-overexpressing cells compared with control cells, whereas there was little or no signal in the presence of NADH ( Figure 6C ). The NADPH-dependent ROS generation was almost completely abolished by DPI (10 µmol/L) but was unaffected by inhibitors of nitric oxide synthase (L-NAME), 
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xanthine oxidase (oxypurinol), or the electron transport chain (rotenone; Figure 6D ).
Nox4D-Generated ROS Mediate Nuclear Redox Signaling in VSMC
ROS generated by Nox family proteins may modulate kinase signaling cascades, such as MAPK activation, 2, 3 and ROS-dependent extracellular-signal-regulated kinase (ERK) activation involving the inactivation of nuclear mitogen-activated kinase phosphatase 1 has been reported. 25 We, therefore, examined the effect of Nox4D on ERK1/2 phosphorylation. Cells infected with Nox4D adenovirus had significantly increased levels of phosphorylated ERK1/2 compared with βGal-infected control cells ( Figure 7A ). Immunofluorescence studies showed that there was a significant increase in nuclear phospho-ERK1/2 ( Figure 8) . A downstream target of active ERK1/2 is the transcription factor Elk-1, a component of the ternary complex that binds the serum response element on target genes and promotes transcription. 26 Levels of phosphorylated Elk-1 were significantly increased in Nox4D-overexpressing cells ( Figure 7A) bottom left) or exon 14 (siN4Ex14; bottom right) for 48 hours were fixed, permeabilized, and stained using Nox4 antibody. Cell nuclei were stained using DAPI in mounting medium. B, VSMCs overexpressing Nox4 (top) or Nox4D (bottom) were permeabilized and stained using anti-Nox4 antibody and phalloidin and mounted using DAPI-containing medium. Scale bars, 50 μm.
transcriptional activity of serum response factor was also observed in Nox4D-overexpressing cells ( Figure 9 ). The ROS dependence of Nox4D-mediated ERK1/2 and Elk-1 activation was further examined. The activation of both ERK1/2 and Elk-1 in Nox4D-overexpressing cells was significantly inhibited by either DPI, the ROS scavenger tiron (4,5-dihydroxy-1,3-benzene disulfonic acid), or cell permeable polyethylene glycol-catalase ( Figure 7B and 7C) .
We generated a Nox4D mutant with a single amino acid substitution in the NADPH-binding domain (proline 130 to histidine, Figure 10A ) that would be expected to impair its activity based on previous studies with Nox4 and Nox2. 27, 28 VSMCs were transfected with wild-type or mutant Nox4D (Nox4DM) and protein expression confirmed by immunoblotting ( Figure 10B ). ROS production in the nuclear fraction was significantly reduced in cells transfected with the Nox4D mutant compared with wild-type Nox4D ( Figure 10C ). In addition, ERK1/2 activation was also significantly reduced in the Nox4DM-transfected compared with Nox4D-transfected cells ( Figure 10D ).
Nox4D-Derived ROS Can Induce DNA Damage
Oxidation-induced DNA damage leads to phosphorylation of H2AX (γ-H2AX), a member of the core histone H2A family. 
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Nuclear γ-H2AX immunostaining was increased in VSMC by exogenous H 2 O 2 or treatment with doxorubicin ( Figure 11 ). Overexpression of Nox4D also significantly increased γ-H2AX levels as assessed by immunostaining and Western blot analyses of whole-cell lysates ( Figure 10E , Figure 11 ). Cells overexpressing the Nox4D mutant showed significantly lower levels of γ-H2AX. Treatment of Nox4D-overexpressing cells with polyethylene glycol-superoxide dismutase, polyethylene glycol-catalase, or DPI all significantly reduced γ-H2AX levels ( Figures 10E and 11 ).
Discussion
In this work, we demonstrate that a 28-kDa splice variant of Nox4, namely Nox4D, that lacks putative transmembrane domains is localized to the nucleus of multiple cell types, including VSMC. Furthermore, Nox4D is found to be functionally active in terms of ROS generation, modulates redoxsensitive nuclear transcription factor activation downstream of the phosphorylation of ERK1/2, and is capable of inducing DNA damage. These results suggest that Nox4D may have important pathophysiogical effects through modulation of nuclear signal transduction and DNA damage. Nox1-4 are predicted to have 6 transmembrane domains and are therefore considered to be membrane-associated proteins. 1 The prototypical Nox oxidase, Nox2, is a plasma membrane-associated enzyme in phagocytes, 1 and Nox1 is also reported to be localized to the plasma membrane. 4 Both endogenous and overexpressed Nox4 has been identified in the ER of various cells, 16, 21 and an ER location of Nox4 was again confirmed in the current study. However, other subcellular locations have also been reported, including the nuclear envelope, 30 mitochondria, 17, 31 and the intranuclear region.
19,32
A possible intranuclear localization of Nox4 is intriguing because it is not immediately obvious how a protein with 6 putative transmembrane domains would localize within the nucleus. Nox4D, however, lacks the transmembrane domains found in full-length Nox4, although it still contains NADPH-and FAD-binding domains 22 and would therefore be expected to be soluble rather than membrane-localized. Indeed, we found a prominent nuclear localization of Nox4D with both a granular distribution within the nuclear matrix and intense focal staining corresponding to the nucleolus. This pattern reflected Nox4D distribution because the major isoform found in nuclear and nucleolar fractions was 28-kDa Nox4; the only splice variant that was detected by real-time polymerase chain reaction was Nox4D; transfected exogenous Nox4D localized to similar locations in the cell; and an siRNA that targeted exon 14 of Nox4, which is present in Nox4D, abolished nuclear immunostaining, whereas an siRNA targeting exon 3 (absent in Nox4D) did not. A nuclear and nucleolar localization of endogenous Nox4D was found not only in primary human and rat A7R5 VSMC but also in a variety of other primary cells and cell lines, including endothelial cells, cardiac fibroblasts, and cardiomyocytes, suggesting that multiple cell types have nuclear Nox4D localization. Previous studies have reported the presence of Nox4D in lung tissue 22 and kidney cells, 33 but subcellular location was not addressed in detail. In A549 cells, transfection of HA-tagged constructs suggested a mainly cytosolic location by immunostaining, but detailed analysis of location was not performed. 22 We found in the present study that transfected Nox4D was located in the nucleus, as well as in extranuclear regions. Analysis of the Nox4D sequence using PSORT II localization prediction software (http://psort. hgc.jp/form2.html) indicates a 17% probability of nuclear localization, suggesting that mechanisms other than a simple nuclear localization sequence may be involved.
We found that Nox4D constitutively generated ROS (ie, without activation by agonists). The capacity for ROS production was confirmed by 4 different assays, namely the homovanillic acid assay for H 2 O 2 , dihydroethidium highperformance liquid chromatography, lucigenin-enhanced chemiluminescence for O 2 − , and the nitroblue tetrazolium assay for electron transfer activity. 24 In addition, it was found that ROS generation was NADPH dependent and inhibited by the potent flavoprotein inhibitor DPI but unaffected by inhibitors of other flavoprotein-containing enzymes, such as NO synthase, xanthine oxidase, and the mitochondrial electron transport chain. Furthermore, ROS production was significantly reduced in cells overexpressing a mutant construct with a single amino acid substitution in the NADPHbinding domain of Nox4D. Taken together, these data provide strong evidence that Nox4D specifically generates ROS as a result of NADPH oxidase activity. The capacity of Nox4D to generate ROS is particularly interesting in light of recent evidence from the Lambeth laboratory 23 that the Nox4 C-terminal dehydrogenase domain, which is essentially preserved in Nox4D, is capable of constitutive electron transfer activity. This differs from the equivalent regions of Nox1, Nox2, and Nox5, which barely have any constitutive electron transfer activity. 23 Entirely consistent with these data, we found that Nox4D has electron transfer activity as assessed by the nitroblue tetrazolium assay. In the full-length Nox proteins, the N-terminal transmembrane portion of the enzyme is thought to facilitate electron transfer across the membrane and thereby generate ROS on the opposite side of the membrane. The constitutive activity of Nox4D together with its lack of transmembrane domains suggests that this isoform may specifically serve to generate ROS in cytosolic compartments.
ROS generation within the nucleus may have several important effects on cellular function. ROS can inactivate nuclearlocalized phosphatases and thereby enhance kinase activation by altering the balance between phosphorylation and dephosphorylation. For example, the oxidative inactivation of the nuclear phosphatase mitogen-activated kinase phosphatase 1 regulates ERK1/2 activation. 15, 25 We found that Nox4D specifically increased phosphorylated ERK1/2 within the nucleus of VSMC, although mitogen-activated kinase phosphatase 1 was not addressed in the current study. ROS may also alter nuclear transcription factor activation, either secondary to activation of relevant kinases or via direct redox effects. We found that activation of the transcription factor Elk-1 was increased by Nox4D downstream of ERK1/2 activation, providing direct evidence for the modulation of nuclear signaling by Nox4D. Interestingly, a significant proportion of nuclear Nox4D was localized to the nucleolus. The mechanisms underlying its localization to this organelle or its specific role therein are currently unclear. However, it is of interest that the nucleolus contains several phosphatases (eg, PP1) 34 that regulate various nucleolar functions, such as ribosomal biosynthesis and nucleolar stress responses. It will be of interest in future studies to probe the roles of Nox4D in different nucleolar and nuclear functions.
Excessive production of ROS also could lead to oxidative DNA damage. To assess whether Nox4D-generated ROS can induce nuclear DNA damage, we studied nuclear γ-H2AX levels in cells transfected with Nox4D or a mutant Nox4D construct. These experiments clearly demonstrated an increase in γ-H2AX levels, which was attributable to ROS and was abrogated in cells transfected with the mutant Nox4D construct. These data indicate that Nox4D has the potential to induce nuclear DNA damage. The precise pathological circumstances under which such damage might occur will need further investigation.
In summary, we identify the presence of a ROS-generating 28-kDa splice variant of Nox4, namely Nox4D, within the nucleus of VSMC and other cell types. Nox4D modulates the nuclear activation of ERK1/2 and the Elk-1 transcription factor, and is capable of inducing nuclear DNA damage, indicating that it may have important roles in nuclear redox signaling.
